Funding for this research was provided by:
Fundação de Amparo à Pesquisa do Estado de São Paulo (2018/17191-7)
Received: 6 December 2019
Accepted: 16 April 2020
First Online: 19 May 2020
Ethics approval and consent to participate
: The protocol has been approved by the local ethics committee (no. 6862/2016) and registered under access code RBR-8gfv5j in the Registro Brasileiro de Ensaios Clínicos (ReBEC). All participants will receive and will sign the informed consent form before the beginning of the trial. All authors declare that there are no potential financial or competitive interests.
: We, all the authors, declare that this article is original, unpublished, and not subject to other journals, as well as express our agreement with submission and copyright. We approval for reprint/adaptation/modification of this material for publication in this journal.Written informed consent for publication of their clinical images was obtained from the patient. A copy of the consent form is available for review by the Editor of this journal.
: The authors declare that they have no competing interests.